Speakers

Adam Gibb

Clinical Research Fellow in Lymphoma

The Christie

Alain Beck

Senior Director, Biologics CMC & developability

Pierre Fabre

Alexei Karpov

Senior Investigator I

Novartis

Andrea Gonzalez-Munoz

Research scientist

AstraZeneca

Andrew Livingston

Professor of Chemical Engineering

Imperial College London

Balakumar Vijayakrishnan

Group Leader - Conjugation

AZ/Spirogen

Barbara Akla

Senior Scientist

Pierre Fabre

Bertrand Cottineau

Head of Research and Development

Novasep

Brian Mendelsohn

Director, Process Development & Tech Transfer

Ajinomoto Bio-Pharma Services

Brian O’Mara

Associate Director - Downstream Process Development

Ambrx

Camille Bailly

Process Development Scientist

Sanofi

Catherine Souder

Lab-Manager

Sanofi

Charles Skarbek

Bioorganic Chemistry Post-doctoral Researcher

Paris Sud

Christian Rohlff

Chief Executive Officer

Oxford BioTherapeutics

Christopher A. Alabi

Associate Professor

Cornell University

Dan Custar

Associate Director - Drug Substance CMC

Mersana

Mary Robinette

Principal Project Engineer - Engineering Department

Merck

Daniel Shweizer

Fellow & Project Leader

Novartis

David Bramhill

Consultant

Bramhill Consulting

David E Thurston

Chief Scientific Officer

Femtogenix

Deya Gonzalez

Associate Professor

University of Swansea

Ed Ha

Founding Principal Scientist

AngieX

Gavin Bennett

Director & Project Leader

Bicycle Therapeutics

Giorgio Salciarini

Technical Business Development Manager

BSP Pharmaceuticals

Gordon Rigg

Independent Consultant

Guy De Roo

Project Leader, Downstream Processing

Synthon

Hans Georg Lerchen

Research & Development

Bayer

Helge Schnerr

Marketing Manager EMEA

FortéBio

Hillary Schuessler

Scientific Leader

GSK

Iontcho Vlahov

Vice President Discovery Chemistry

Endocyte

Jack Wang

Senior Scientist

Johnson & Johnson

Jacopo Millul

Research Associate Scientist

Philogen

Jamie Baker

Reader in Chemical Biology

University College London

Jeremy Parker

Senior Principal Scientist - New Modalities & Tissue Targeting

AstraZeneca

Jia He

Analyst

Beacon Target Therapies

John Babcook

Senior Vice President of Discovery Research

Zymeworks

John Harlan

Senior Principal Research Scientist

AbbVie

Juan Carlos Cordova

Senior Scientist, Process Development, Bioconjugation

Abzena

Julian Andreev

Senior Staff Scientist & Research Fellow

Regeneron

Julie Desrivot-Quénelle

Project Lead - Pharmacokinetic Pharmacodynamic

Pierre Fabre

Julien Dugal-Tessier

Director of Innovative Chemistry and Bioconjugation

NJ Biopharmaceuticals

Justin Mason Holme

Director

HPAPI Project Services Limited

Luc Desnoyers

Sr. Director of Translational Sciences

CytomX

Markus Eser

Laboratory Head

Bayer

Martin Axon

Principal Occupational Hygienist

Safebridge

Naresh Jain

President & Chief Executive Officer

NJ Biopharmaceuticals LLC

Nathan Alves

Assistant Professor

Indiana University School of Medicine

Nicholas Choong

Executive Medical Director and Global Development Lead of the LIV-1 ADC program

Seattle Genetics

Phil Howard

Chief Scientific Officer

Spirogen

Pierre Guibal

Deputy Head, Analytical Development, BioAnalytics

Sanofi

Prathap Kumar Mahalingaiah

Senior Scientist III 

AbbVie

Rakesh Dixit

CEO & Founder

BioNavigen

Rick Powers

Independent Consultant

Robert Sussman

Managing Director

Safebridge Consultants

Sally Ward

Director of Translational Immunology, Centre for Cancer Immunology

University of Southampton

Samuele Cazzamalli

Research Scientist

Philogen

Sibylle Heidelberger

Senior Specialist - Support

Sciex

Simon Chivers

Independent Consultant

Steffan Woell

Principal Scientist

Merck

Steve Conlan

Professor

University of Swansea

Subhash Chauhan

Professor

The University of Texas Rio Grande Valley

Thomas Pillow

Senior Scientist

Genentech

Thorsten Sperber

Global Head Medical Affairs

Immunomedics

Trevor Hallam

Chief Scientific Officer

Sutro Bio

Ulf Grawunder

Chief Executive Officer & Founder

NBE Therapeutics

Vijay Chudasama

Professor of Organic Chemistry & Chemical Biology

University College London

Vítor Sousa

Senior Manager, R&D Department

Cerbios-Pharma